Literature DB >> 21859330

Seroprevalence of Toxoplasma gondii in dogs in Shandong, Henan, and Heilongjiang Provinces, and in the Xinjiang Uygur Autonomous Region, People's Republic of China.

Yongxia Liu1, Gaoming He, Ziqiang Cheng, Yayin Qi, Jianzhu Liu, Hongchao Zhang, Guodong Liu, Dayou Shi, Dubao Yang, Shujing Wang, Zhenyong Wang.   

Abstract

Seroprevalence of Toxoplasma gondii infection was determined in sera of 632 dogs (551 pets, 81 strays) from Shandong, Henan, and Heilongjiang Provinces, and in the Xinjiang Uygur Autonomous Region, People's Republic of China (PRC), using the indirect hemagglutination assay (cutoff titer 1:64 or higher); 11.1% were seropositive. The seroprevalence in stray dogs and in ≥3-yr-old dogs was significantly higher (P < 0.05) than that in household dogs and in <3-yr-old dogs. There were no significant differences in terms of gender, breed, or locality (P ≥ 0.05). The results indicate that T. gondii infections are common in dogs in PRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859330     DOI: 10.1645/GE-2892.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Seroprevalence and risk factors of Toxoplasma gondii infection in stray dogs in northern China.

Authors:  Xiao-Xuan Zhang; Ya-Nan Cai; Chun-Feng Wang; Jing Jiang; Ying-Tian Xu; Gui-Lian Yang; Quan Zhao
Journal:  Parasitol Res       Date:  2015-09-25       Impact factor: 2.289

2.  Seroprevalence of Toxoplasma gondii Infection in Pet Dogs in Anhui Province, China.

Authors:  Zhijin Sheng; Yu Jin; Yong Yao; Saeed El-Ashram; Jijia Shen; Xue-Long Wang; Yongsheng Ji
Journal:  Iran J Parasitol       Date:  2020 Jul-Sep       Impact factor: 1.012

3.  Low prevalence of Neospora caninum and Toxoplasma gondii antibodies in dogs in Jilin, Henan and Anhui Provinces of the People's Republic of China.

Authors:  Yurong Yang; Qiongfang Zhang; Yangguang Kong; Yuqing Ying; Oliver Chun Hung Kwok; Hongde Liang; Jitender Prakash Dubey
Journal:  BMC Vet Res       Date:  2014-12-12       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.